Literature DB >> 2572266

Effects of xamoterol on sodium excretion in volunteers.

P Y Zech1, N Pozet, M A Day, H M Snow, O Madonna, A Hadj-Aissa.   

Abstract

Xamoterol has been shown to reduce the frequency of oedema and lung crepitations in heart failure. We examined its effects on blood pressure and renal function in healthy volunteers. Systolic blood pressure rose, sodium and chloride excretion increased and there was a strong correlation in individual subjects between rises in systolic blood pressure and in sodium excretion. Although no changes in glomerular filtration rates were seen, changes sufficient to explain the observed rise in sodium excretion are well within the experimental error of this study. Xamoterol may increase sodium excretion by an action on renal haemodynamics.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572266      PMCID: PMC1379887          DOI: 10.1111/j.1365-2125.1989.tb03584.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  2 in total

1.  A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.

Authors:  M J Jamieson; J Webster; G Fowler; J Rawles; F W Smith; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

2.  Renal effects of xamoterol in patients with moderate heart failure.

Authors:  H E Bøtker; H K Jensen; L R Krusell; E V Sørensen
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.